We are a leading healthcare company that is pioneeringthe world’s most advanced pharmacy® and our clinical research and innovations are part ofMedco making medicine smarter™ for more than 65 million members in 2011. Medco provides clinically driven pharmacy services designed to improve the quality of care and lower total healthcare costs for private and public employers, health plans, labor unions and government agencies of all sizes, and for individuals served by Medicare Part D Prescription Drug Plans. Our unique Medco Therapeutic Resource Centers® , which conduct therapy management programs using Medco Specialist Pharmacists who have expertise in the medications used to treat certain chronic conditions, as well as Accredo Health Group, Medco’s Specialty Pharmacy, represent innovative models for the care of patients with chronic and complex conditions. Additionally, Medco has capabilities and expertise in post-approval safety and economics outcomes research such as Risk Evaluation and Mitigation Strategies for biotechnology and other pharmaceutical drugs through our subsidiary, United BioSource Corporation® Our business model requires collaboration with payors, retail pharmacies, physicians, pharmaceutical manufacturers, the Centers for Medicare & Medicaid Services (“CMS”) for Medicare, and, particularly in Specialty Pharmacy, collaboration with other third-party payors such as health insurers, and state Medicaid agencies. Our programs and services help control the cost and enhance the quality of prescription drug benefits. We accomplish this by providing pharmacy benefit management (“PBM”) services through our national networks of retail pharmacies and our own mail-order pharmacies, as well as through Accredo Health Group.
![Medco Health Solutions logo](https://files.capedge.com/424B5/0001193125-14-221202/g732241g88u05.jpg)
Company profile
Ticker
MHS
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Merck Medco Managed Care LLC
SEC CIK
Corporate docs
IRS number
223461740
Latest filings (excl ownership)
424B5
Prospectus supplement for primary offering
22 Nov 17
424B5
Prospectus supplement for primary offering
20 Nov 17
S-3ASR
Automatic shelf registration
14 Nov 17
424B5
Prospectus supplement for primary offering
30 Jun 16
424B5
Prospectus supplement for primary offering
29 Jun 16
424B5
Prospectus supplement for primary offering
24 Feb 16
424B5
Prospectus supplement for primary offering
22 Feb 16
POSASR
Automatic shelf registration (post-effective amendment)
22 Feb 16
424B5
Prospectus supplement for primary offering
4 Jun 14
424B5
Prospectus supplement for primary offering
2 Jun 14
Latest ownership filings
11-K
Annual report of employee stock purchases
20 Jun 11
11-K
Annual report of employee stock purchases
21 Jun 10
11-K
Annual report of employee stock purchases
19 Jun 09
11-K
Annual report of employee stock purchases
23 Jun 08
11-K
Annual report of employee stock purchases
25 Jun 07
11-K
Annual report of employee stock purchases
28 Jun 06
11-K
Annual report of employee stock purchases
20 Jun 05
11-K
Annual report of employee stock purchases
25 Jun 04